Skip to content

The study of the effects of general anesthesia using Remimazolam on vital signs such as cardiovascular and blood pressure in surgical patients

Effects on the cardiac conduction system revealed by analysis of heart rate variability in the use of Remimazolam (Single-blind, a prospective test) - Effects of Remimazolam on the cardiac conduction system (Single-blind, prospective study)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044311
Enrollment
70
Registered
2021-06-01
Start date
2021-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All diseases that require surgery under general anesthesia

Interventions

Induce anesthesia using Remimazolam. Induce anesthesia using Propofol.

Sponsors

Kindai University Faculty of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients undergoing general anesthesia, regardless of gender. 2) Patients scheduled to undergo mechanical ventilation management by tracheal intubation 3) Patients with ASA classification I or II 4) Patients who can fully explain the complications, indications, and disadvantages associated with inferior alveolar nerve conduction anesthesia using detailed explanatory documents, and obtain written consent (informed consent) at their own will.

Exclusion criteria

Exclusion criteria: 1) Patients under the age of 20 at the time of obtaining the consent form 2) Patients with allergies, hypersensitivity or tolerance to the drugs used 3) Patients who meet the contraindications listed in the package insert of the drug to be used 4) Patients with AST (GOT) or ALT (GPT) of 100 IU / L or more in preoperative general clinical examination 5) Patients with Child-Pugh classification B or C 6) Patients with serum creatinine of 2.0 mg / dL or higher in general preoperative laboratory tests 7) Patients who have been using benzodiazepines for a long time 8) Patients with organic abnormalities in the brain who may not be able to properly measure EEG and BIS values 9) Patients scheduled to undergo epidural anesthesia / spinal anesthesia 10) Patients with cardiac pacemakers and ICDs 11) Lactating patients (except with the positive consent of the patient) 12) Other patients judged to be inappropriate by the principal investigator

Design outcomes

Primary

MeasureTime frame
1, ECG (RR interval, Tp-e, QTc time) 2, Blood pressure 3, Heart rate, pulse rate

Countries

Japan

Contacts

Public ContactShota Tsukimoto

Kindai University Faculty of Medicine Dapartment of Anesthesiology

s-tsukimoto@med.kindai.ac.jp072-366-0221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026